Anti-DCL1 (phospho-Ser567)
DLC1 functions as a GTPase-activating protein specific for Rho and an activator of PLCD1 in vivo and induces morphological changes and detachment through cytoskeletal reorganization. DLC1 is a candidate tumor suppressor gene for human liver cancer, as well as for prostate, lung, colorectal, and breast cancers.
Product Specifications
CAS Number
9007-83-4
Reactivity
Human
Immunogen
Peptide sequence that include the phosphorylation site on Ser-567
Clonality
Polyclonal
Type
Antibodies-Polyclonal
Applications
WB,ELISA
Concentration
100ug/100ul
Purity
Affinity purified
Buffer
PBS, pH 7.4 with 0.02% sodium azide.
Shipping Conditions
Ice Pack
Storage Conditions
This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt.
Fragment
IgG
Applications Notes
WB: 1:1000, ELISA: 1:20000
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E45H30698E1 50 µg
Breast cancer suppressor candidate 1 (VWA5A) (NM_198315) Human Recombinant Protein
Ask
View Details 
MBS1153462-01 0.02 mg (E-Coli)
Recombinant Pelodictyon phaeoclathratiforme Aspartate 1-decarboxylase (panD)
Ask
View Details MBS1153462-02 0.1 mg (E-Coli)
Recombinant Pelodictyon phaeoclathratiforme Aspartate 1-decarboxylase (panD)
Ask
View Details 
MBS1153462-03 0.02 mg (Yeast)
Recombinant Pelodictyon phaeoclathratiforme Aspartate 1-decarboxylase (panD)
Ask
View Details MBS1153462-04 0.1 mg (Yeast)
Recombinant Pelodictyon phaeoclathratiforme Aspartate 1-decarboxylase (panD)
Ask
View Details